DIFFERENTIAL EXPRESSION OF VIRAL AND HUMAN INTERLEUKIN-10 (IL-10) BY PRIMARY B-CELL TUMORS AND B-CELL LINES

被引:54
作者
STEWART, JP
BEHM, FG
ARRAND, JR
ROONEY, CM
机构
[1] ST JUDE CHILDRENS RES HOSP, DEPT PATHOL, MEMPHIS, TN 38101 USA
[2] CHRISTIE CRC CANC CTR, PATERSON INST CANC RES, DEPT MOLEC BIOL, MANCHESTER M20 9BX, LANCS, ENGLAND
[3] UNIV TENNESSEE, DEPT PATHOL, MEMPHIS, TN USA
关键词
D O I
10.1006/viro.1994.1236
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human and viral interleukin-10 (IL-10) possess growth factor activity for human B cells and may act as autocrine growth factors in B cell malignancies. To study this possibility we have measured viral (v) and human (h) IL-10 expression in EBV-positive and negative B lineage tumors and tumor cell lines. Previous studies demonstrated IL-10 expression in cell lines and now we describe the pattern of IL-10 expression in primary Burkitt's lymphoma (BL) tumor biopsies and in BL lines of defined phenotypes, vIL-10 was expressed during the lytic (productive) phase of EBV infection, but not during virus latency. Although hIL-10 was expressed in the majority of B cell lines, it was not expressed in two BL biopsy specimens. Expression of hIL-10 did not correlate with the presence of EBV, but was associated with the differentiation stare of the B cell line. Thus, vIL-10 may enhance the persistence of B cells infected at sites of virus replication, and while hIL-10 may be a factor in the growth both in vivo and in vitro of some BLs and EBV-transformed B cells, it is not an absolute requirement. (C) 1994 Academic Press, Inc.
引用
收藏
页码:724 / 732
页数:9
相关论文
共 45 条
[1]   MOLECULAR-CLONING OF THE COMPLETE EPSTEIN-BARR VIRUS GENOME AS A SET OF OVERLAPPING RESTRICTION ENDONUCLEASE FRAGMENTS [J].
ARRAND, JR ;
RYMO, L ;
WALSH, JE ;
BJORCK, E ;
LINDAHL, T ;
GRIFFIN, BE .
NUCLEIC ACIDS RESEARCH, 1981, 9 (13) :2999-3014
[2]  
BENJAMIN D, 1992, BLOOD, V80, P1289
[3]   STAGES OF B-CELL DIFFERENTIATION IN HUMAN LYMPHOID-TISSUE [J].
BHAN, AK ;
NADLER, LM ;
STASHENKO, P ;
MCCLUSKEY, RT ;
SCHLOSSMAN, SF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 154 (03) :737-749
[4]   EPSTEIN-BARR-VIRUS TRANSFORMATION INDUCES LYMPHOCYTES-B TO PRODUCE HUMAN INTERLEUKIN-10 [J].
BURDIN, N ;
PERONNE, C ;
BANCHEREAU, J ;
ROUSSET, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :295-304
[5]  
CLEARY ML, 1986, EPSTEINBARR VIRUS RE, P163
[6]   INTERLEUKIN-10 AND TRANSFORMING GROWTH-FACTOR-BETA COOPERATE TO INDUCE ANTI-CD40 ACTIVATED NAIVE HUMAN B-CELLS TO SECRETE IMMUNOGLOBULIN-A [J].
DEFRANCE, T ;
VANBERVLIET, B ;
BRIERE, F ;
DURAND, I ;
ROUSSET, F ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (03) :671-682
[7]   INVIVO PRODUCTION OF INTERLEUKIN-10 BY MALIGNANT-CELLS IN AIDS LYMPHOMAS [J].
EMILIE, D ;
TOUITOU, R ;
RAPHAEL, M ;
PEUCHMAUR, M ;
DEVERGNEE, O ;
REA, D ;
COUMBRARAS, J ;
CREVON, MC ;
EDELMAN, L ;
JOAB, I ;
GALANAUD, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (11) :2937-2942
[8]   VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITTS LYMPHOMA [J].
EPSTEIN, MA ;
ACHONG, BG ;
BARR, YM .
LANCET, 1964, 1 (733) :702-+
[9]   PROGENITOR AND PRE-B LYMPHOCYTES TRANSFORMED BY EPSTEIN-BARR-VIRUS [J].
ERNBERG, I ;
FALK, K ;
HANSSON, M .
INTERNATIONAL JOURNAL OF CANCER, 1987, 39 (02) :190-197
[10]  
FIORENTINO DF, 1991, J IMMUNOL, V147, P3815